Navigation Links
T cell immunotherapy: Promising results in children and adults with leukemia
Date:12/7/2013

complete responses. Therefore, 18 of the 24 pediatric and adult patients had ongoing complete responses at a median follow-up of 2.6 months after treatment.

The trials, a collaboration between The Children's Hospital of Philadelphia and the University of Pennsylvania, are overseen by Carl H. June, M.D., the Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine and director of Translational Research in Penn's Abramson Cancer Center.

Grupp presented alongside Penn investigator Michael Kalos, Ph.D., during the press program. Kalos showed that measuring the number and activity of engineered T cells in patients with both ALL and chronic lymphocytic leukemia (CLL) who were treated with this investigational approach provided a useful gauge of treatment success.

A relatively new approach in cancer treatment, this type of immunotherapy relies on T cells, the workhorses of the body's immune system. Because B cells become cancerous in specific leukemias such as ALL, CTL019 cells function as cancer hunters, killing the leukemia cells that normally evade regular T cell surveillance. Researchers first extract a patient's own T cells and genetically modify them in Penn's cell and vaccine production facility to create CTL019 cells. Bioengineering techniques are used to reprogram each patient's T cells into chimeric antigen receptor cellsthe CTL019 cellscustom-designed to bind to a protein called CD19 that exists only on the surface of B cells. Then, the cells are returned to the patient's body, where they proliferate and then eliminate B cells. Moreover, they persist in the circulation, helping to guard against the cancer's recurrence.

The current study reflects an ongoing collaboration between Grupp and the Penn Medicine scientists who originally developed this personalized cell therapy as a treatment for adult patients with CLL, another B-cell leukemia.

The CHOP/Penn research colleagues ada
'/>"/>

Contact: Rachel Salis-Silverman
Salis@email.chop.edu
267-970-3685
Children's Hospital of Philadelphia
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. International gene therapy trial for bubble boy disease shows promising early results
2. Newly identified proteins make promising targets for blocking graft-vs.-host disease
3. Mouse studies reveal promising vitamin D-based treatment for MS
4. Mechanism offers promising new approach for harnessing the immune system to fight cancer
5. Scientists identify promising antiviral compounds
6. Horizon Pharma Abstract Prizes recognize promising fellows and students
7. Testing method promising for spinal cord injuries, multiple sclerosis
8. Large animal models of Huntingtons disease offer new and promising research options
9. Discovery could increase efficacy of promising cystic fibrosis drug
10. Sanford-Burnham and 60° Pharmaceuticals to pursue promising target for the treatment of dengue fever
11. Research finds promising approaches to prevent Latino childhood obesity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
T cell immunotherapy: Promising results in children and adults with leukemia
(Date:5/14/2015)... May 14, 2015 Research and Markets ... "Fingerprint Sensors Market in Smart Mobile Devices " ... believes that 2014 was a watershed year for fingerprint ... of ,Apple Pay,. Apple gave fingerprint sensors a raison ... service. Fingerprint sensors are a must-have feature in flagship ...
(Date:5/11/2015)... Calif. , May 11, 2015  Synaptics ... of human interface solutions, today announced the appointment ... President and Chief Financial Officer, reporting to ... replaces Synaptics, current Chief Financial Officer, Kathleen ... 2014. Mr. Ali brings extensive ...
(Date:5/11/2015)... N.Y. , May 11, 2015 Curemark ... announced the start of a new Phase III double ... of its novel formulation, CM-AT, on all children ages ... of its FDA Phase III double blinded clinical trial ... had low levels of the digestive enzyme chymotrypsin. This ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... of an unknown perpetrator who has committed a crime will ... MC scientists, in collaboration with their Polish colleagues, have discovered ... color. Their findings will be published today in the Springer ... that on the basis of DNA information it is possible ...
... (PHILADELPHIA) An international team of researchers led ... Penn Medicine,s Institute for Translational Medicine and Therapeutics, ... Paris-based Fondation Leducq to study the molecular genetics ... Mechanisms of Novel Genes Associated with Plasma Lipids ...
... Many young people who,ve just learned that they have cancer ... lives could rob them of their ability ever to have ... population: Of the 1.5 million people diagnosed with cancer in ... The good news, according to an article in ...
Cached Biology News:Hair color of unknown offenders is no longer a secret 2Penn Medicine researcher receives $6 million grant for cardiovascular disease study 2Advancements in fertility preservation provide oncology patients new options 2Advancements in fertility preservation provide oncology patients new options 3
(Date:6/1/2015)... Esperance Pharmaceuticals Inc. today reported positive results ... in ovarian cancer patients resistant to paclitaxel. EP-100 is ... cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors ... wide range of cancers. Results of ... were presented at the 2015 ASCO Annual Meeting ...
(Date:6/1/2015)... 29, 2015 Research and Markets ... of the "2015 Strategies in European ... their offering. This new 273-page ... diagnostic market, including emerging tests, technologies, instrumentation, ... of leading suppliers. Companies Mentioned: ...
(Date:6/1/2015)... Research and Markets( http://www.researchandmarkets.com/research/5j2hpk/2015_strategies ) ... "2015 Strategies in the US Point-of-Care/POC Clinical ... This new 373-page report contains ... of the POC clinical chemistry market, including ... trends, competitive landscape, and emerging opportunities for ...
(Date:6/1/2015)... Research and Markets( http://www.researchandmarkets.com/research/n2rvxp/2015_assessments ) ... "2015 Assessments of Leading Microbiology Market Players--Insightful ... Entrants" report to their offering. ... provides insightful profiles of leading microbiology market ... The report presents strategic assessments, including sales, ...
Breaking Biology Technology:Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 2Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 3Assessments of Leading Microbiology Market Players 2015 - Profiles of Major Suppliers and Recent Market Entrants 2
... - CEO Michael V. Novinski to Discuss Plans ... CEDAR KNOLLS, N.J., Jan. 31 Emisphere,Technologies, Inc. ... will host a,teleconference on Thursday, February 7, at ... V. Novinski will discuss the company,s,emerging business strategy. ...
... Names Board of Directors, SAN DIEGO, Jan. ... developing therapeutics for the,treatment of Alzheimer,s disease, announced ... Series A round of financing. The financing was ... Alta Partners. Additional,investors included AgeChem Venture Fund, and ...
... Foundation Continues Research Initiatives in Search of a Cure and Therapies ... ... N.J., Jan. 31 The Christopher and Dana,Reeve Foundation (CDRF), which ... improving the quality of life for people,living with paralysis through grants, ...
Cached Biology Technology:Emisphere to Host Business Strategy Conference Call on February 7 2Emisphere to Host Business Strategy Conference Call on February 7 3Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments 2Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments 3Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants 2Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants 3
... Science LAS-3000 imaging system combines new ... user interface, providing significantly improved system ... modularities. The system is especially dedicated ... standard system for Western blotting applications.,Fuiji's ...
This pump accomodates StemSep ; pump feed columns of the following sizes : 0.3in., 0.5in., 0.6in., and 1.0in.....
... m7G Capping system features the ... of the components needed to ... the end of di- or ... feature high efficiency capping (virtually ...
... Removal , , Removes ... cross-reactivity with other proteins , Simple, just ... Economical new surface technology, not based on ... with protein analysis. SurfactAway offers a simple ...
Biology Products: